SABIC (2010) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
1 Jul, 2026Executive summary
Revenue for Q1 2026 was $7.0 billion (SAR 26.2 billion), down 6% quarter-on-quarter and 10.7% year-over-year, driven by lower sales volumes but partially offset by higher prices.
Adjusted EBITDA rose 25% sequentially to $1.1 billion (SAR 4.15 billion), with margin improving to 15.9% from 11.9% in Q4 2025, reflecting cost discipline and higher prices.
Adjusted net income reached $218 million (SAR 816 million), a turnaround from a loss in Q4 2025.
Transformation initiatives delivered $220 million recurring EBITDA uplift in Q1 2026, supporting progress toward 2030 targets.
Strategic divestments in European Petrochemicals and Engineering Thermoplastics businesses are underway, impacting reported results and supporting portfolio optimization.
Financial highlights
Q1 2026 revenue was $7 billion (SAR 26.15 billion), down 6% quarter-on-quarter and 11% year-over-year due to lower sales volumes and plant maintenance.
Adjusted EBITDA increased 25% quarter-over-quarter to $1.1 billion (SAR 4.15 billion); margin improved to 15.9%.
Adjusted net income was $218 million (SAR 816 million), compared to a loss in Q4 2025.
Free cash flow was negative at -$70 million (SAR -0.27 billion), impacted by higher working capital.
Net debt stood at $0.74 billion (SAR 2.77 billion) as of March 31, 2026.
Outlook and guidance
Capital investment guidance for 2026 is $3.5–$4 billion, with a focus on sustainable earnings growth and cash generation.
Management expects continued volatility due to geopolitical risks, especially in the Middle East and Strait of Hormuz.
Portfolio optimization, transformation initiatives, and selective growth investments, especially in China, remain key priorities.
Latest events from SABIC
- EBITDA and net income rose despite lower revenue, with higher margins and innovation gains.2010
Q4 20249 Jul 2026 - Q2 2024 net income jumped 85% YoY on higher sales, margin gains, and portfolio optimization.2010
Q2 20248 Jul 2026 - Q3 2024 revenue up 3% YoY, net income rebounded, and major divestments drove portfolio gains.2010
Q3 20241 Jul 2026 - Q1 2025 revenue stable, net loss narrowed, and transformation, growth, and cost-saving initiatives advanced.2010
Q1 20251 Jul 2026 - Revenue fell but EBITDA margin and cash flow remained strong amid persistent overcapacity.2010
Q3 20251 Jul 2026 - Adjusted EBITDA jumped 40% in Q2 2025, but net loss reflects major impairment charges.2010
Q2 20251 Jul 2026 - Adjusted profits remained resilient and free cash flow rose 17% despite margin pressure.2010
Q4 20255 Mar 2026